Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-κB activation

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 297-304

  Higuchi, Masahiro ^a,c   Singh, Sanjaya ^a   Jaffrezou, Jean Pierre ^b   Aggarwal, Bharat B ^a,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CELL MEMBRANE PERMEABILITY; COMPLICATION; DRUG INDUCED DISEASE; ENZYME ACTIVATION; ENZYME INHIBITION; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; BASE SEQUENCE; CERAMIDES; DNA DAMAGE; HUMANS; INDOLIZINES; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHENETHYLAMINES; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029952514     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666.
2. Aggarwal, B. B., and J. Vilcek (eds.) 1992. Tumor Necrosis Factor Structure, Function, and Mechanism of Action. Marcel Dekker Press, New York, pp. 1-600.
3. Loetscher, H. Y., C. E. Pan, H. W. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55kd tumor necrosis factor receptor. Cell 61:351.
4. Schall, T. J., M. Lewis, K. J. Koller, A. Lee, G. C. Rice, G. H. W. Wong, T. Gatanaga, G. A. Granger, R. Lentz, H. Raab, W. J. Kohr, and D. V. Goeddel. 1990. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361.
5. Smith, C.A., T. Davis, D. Anderson, L. Solam, M. P. Beckmann, R. Jerzy, S. K. Dower, D. Cosman, and R. G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
6. Kohno, T., M. T. Brewer, S. L. Baker, P. E. Schwaltz, M. W. King, K. K. Hale, C. H. Squires, R. C. Thompson, and J. L. Vannice. 1990. Second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87:8331.
7. Espevik, T., M. Brockhaus, H. Loetscher, U. Nostad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171:415.
8. Englemann, H., H. Holtman, C. Brakebusch, Y. S. Avin, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497.
9. Thoma, B., M. Grell, K. Pfizenmaier, and P. Scheurich. 1990. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172:1019.
10. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynold, M. A. Palladino, Jr., and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
11. Wong, G. H. W., L. A. Tartaglia, M. S. Lee, and D. V. Goeddel. 1992. Antiviral activity of tumor necrosis factor (TNF) is signaled through the 55-kDa receptor, type I TNF. J. Immunol. 149:3350.
12. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxin shock, yet succumb to L. monocytogenes infection. Cell 73:457.
13. Higuchi, M., and B. B. Aggarwal. 1993. P80 form of the human tumor necrosis factor receptor is involved in DNA fragmentation. FEBS Lett. 331:252.
14. Heller, R., K. Song, N. Fan, and D. J. Chang. 1992. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70:47.
15. Higuchi, M., and B. B. Aggarwal. 1994. Differential roles of two forms of TNF receptor on TNF-induced cytotoxicity: DNA fragmentation and differentiation. J. Immunol. 152:4017.
16. Matthews, N., M. L. Neale, S. K. Jackson, and J. M. Stark. 1987. Tumor cell killing by tumor necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62:153.
17. 2 activation caused by tumor necrosis factor. J. Immunother. 2:41.
18. Schulze-Osthoff, K., C. Bakker, B. Vanhaesebroeck, R. Beyaert, W. A. Jacob, and W. Fiers. 1992. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 267:5317.
19. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:3095.
20. Kobayashi, Y., J. Sawada, and T. Osawa. 1979. Activation of membrane phospholipase A by guinea pig lymphotoxin (GLT). J. Immunol. 122:791.
21. 2 activation in tumor cell killing by tumor necrosis factor. Immunology 64:81.
22. 2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268:11290.
23. Ruggiero, V., S. E. Johnson, and C. Baglioni. 1987. Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell. Immunol. 107:317.
24. Suffys, P., R. Beyaert, F. Van Roy, and W. Fiers. 1988. Involvement of a serine protease in tumor-necrosis-factor-mediated cytotoxicily. Eur. J. Biochem. 178: 257.
25. Agarwal, S., B.-E. Drysdale, and H. S. Shin. 1988. Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. J. Immunol. 140:4187.
26. Lichtenstein, A., J. F. Gera, J. Andrew, J. Berenson, and C. F. Ware. 1991. Inhibitors of ADP-ribose polymerase decrease the resistance of HER2/neu-expressing cancer cells to the cytotoxic effects of tumor necrosis factor. J. Immunol. 146:2052.
27. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y. A. Hannun. 1993. Programmed cell death induced by ceramide. Science 259:1769.
28. Jarvis, W. D., R. N. Kolesnick, F. A. Fornari, R. S. Traylor, D. G. Gewirtz, and S. Grant. 1994. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelinase pathway. Proc. Natl. Acad. Sci. USA 91:73.
29. Kim, M.-Y., C. Linardic, L., Obeid, and Y. Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma interferon: specific role in cell differentiation. J. Biol. Chem. 266:484.
30. Schutze, S., K. Potthof, T. Machleidt, and M. Kronke. 1992. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765.
31. Yang, Z., M. Costanzo, D. W. Golde, and R. N. Kolesnick. 1993. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor-kappa B translocation in intact HL-60 cells. J. Biol. Chem. 268:20520.
32. Dbaido, G. S., L. M. Obeid, and Y. A. Hannun. 1993. Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide: dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. J. Biol. Chem. 268:17762.
33. Betts, J. C., A. B. Agranoff, G. J. Nabel, and J. A. Shayman. 1994. Dissociation of endogenous cellular ceramide from NF-kappa B activation. J. Biol. Chem. 269:8455.
34. Yanaga, F., and S. P. Watson. 1994. Ceramide does not mediate the effect of tumor necrosis factor alpha on the superoxide radical generation in human neutrophils. Biochem. J. 298:733.
35. Ohta, H., Y. Yatomi, E. A. Sweeney, S. Hakomori, and Y. Igarashi. 1994. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor alpha in human neutrophils. FEBS Lett. 355:267.
36. Johns, L. D., T. Sarr, and G. E. Ranges. 1994. Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-kappa B. J. Immunol. 152:5877.
37. Hannun, Y. A., and C. M. Linardic. 1993. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim. Biophys. Acta 1154:223.
38. Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kronke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005.
39. Bose, R., M. Verheij, A. Haimovitz-Friedman, K. Scotto, Z. Fuks, and R. Kolesnick. 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405.
40. Jaffrezou, J-P., J.-M. Herbert, T. Levada, M.-N. Gau, P. Chatelain, and G. Laurent. 1991. Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein. J. Biol. Chem. 266: 19858.
41. Jaffrezou, J-P., T. Levada, P. Chatelain, and G. Laurent. 1992. Modulation of subcellular distribution of doxorubicin in multidrug resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino]propyloxy)- benzenesulfonyl)) indolizine. Cancer Res. 52:6440.
42. Higuchi, M., S. Singh, and B. B. Aggarwal. 1995. Characterization of apoptotic effects of human tumor necrosis factor: development of highly rapid and specific bioassay for human tumor necrosis factor and lymphotoxin using human target cells. J. Immunol. Methods 178:173.
43. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:6419.
44. Chaturvedi, M., R. LaPushin, and B. B. Aggarwal. 1994. Qualitative and quantitative differences between tumor necrosis factor and lymphotoxin for mediation of early and late cellular responses. J. Biol. Chem. 269:14575.
45. Reddy, S. A. G., M. M. Chaturvedi, B. G. Darnay, H. Chan, M. Higuchi, and B. B. Aggarwal. 1994. Reconstitution of NF-κB activation induced by tumor necrosis factor requires membrane-associated components: comparison with pathway activated by ceramide. J. Biol. Chem. 269:25369.
46. Quintern, L. E., and K. Sandhoff. 1991. Human acid sphingomyelinase from human urine. Methods Enzymol. 197:536.
47. Ito, A., and K. Horigome. 1995. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J. Neurochem. 65:463.
48. Hannun, A. Y., C. R. Loomis, A. H. Merrill, Jr., and R. M. Bell. 1986. Sphingosine inhibition of protein kinase C and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261:12604.
49. Zhang, L., M. Higuchi, K. Totpal, M. M. Chaturvedi, and B. B. Aggarwal. 1994. Staurosporine induces the cell surface expression of both forms of human tumor necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response. J. Biol. Chem. 269:10270.
50. Totpal, K., S. Agarwal, and B. B. Aggarwal. 1992. Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells. Cancer Res. 52:2557.
51. Singh, S., and B. B. Aggarwal. 1995. Protein tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB. J. Biol. Chem. 270:10631.
52. Doborowsky, R. T., and Y. A. Hannun. 1992. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267:5048.
53. Muller, G., M. Ayoub, P. Storz, J. Rennecke, D. Fabbro, and K. Pfizenmaier. 1995. PKC zeta is a molecular switch in signal transduction of TNF-α, bi-functionally regulated by ceramide and arachidonic acid. EMBO J. 14:1961.
54. Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227.